4606 Fessenden Street NW Washington DC 20016, Washington, DC · JAMES HALL
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERI… |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2025 | TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERI… |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2025 | TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — |
| Name | Disclosed Prior Position |
|---|---|
| JAMES BRYANT HALL | Staff Director, Senate Veterans Affairs Committee; Legislative Director,Senator Bob Graham |